Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-24
DOI
10.1038/s41467-020-17525-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial life discontinues without Erk
- (2019) Yihai Cao JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-Angiogenics: Their Value in Colorectal Cancer Therapy
- (2018) Andreas Seeber et al. Oncology Research and Treatment
- Dual roles of endothelial FGF-2–FGFR1–PDGF-BB and perivascular FGF-2–FGFR2–PDGFRβ signaling pathways in tumor vascular remodeling
- (2018) Kayoko Hosaka et al. Cell Discovery
- FGF-dependent metabolic control of vascular development
- (2017) Pengchun Yu et al. NATURE
- Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism
- (2016) Yunlong Yang et al. Nature Communications
- VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
- (2014) Yihai Cao Nature Reviews Endocrinology
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis
- (2013) Kayoko Hosaka et al. Nature Communications
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
- (2011) Annika Armulik et al. DEVELOPMENTAL CELL
- PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
- (2011) Yuan Xue et al. NATURE MEDICINE
- Tumor angiogenesis and molecular targets for therapy
- (2009) Yihai Cao Frontiers in Bioscience-Landmark
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
- (2009) E.-M. Hedlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Drug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies
- (2008) Anke Reinacher-Schick et al. Nature clinical practice. Gastroenterology & hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now